Ann: TGA clearnance to assist treatment of Pelvic Organ Prolapse, page-21

This post is an attempt to explain the process and what's happening, to any holders who don't understand.

Navigant Capital has a brief from us to broker a deal whether that be a sale of company or product/s, a partner, or a license.  All options are being enticed and will be considered.  Two products with all options considered makes this a big, costly, and time consuming process.
One of the many preliminary tasks is to analyze our company and products then determine some reasonable product and company valuations factoring many things including potential (massive); and establishing price expectations.  That both products are ready to go will be just one big plus.
Then they send a summary to potential respondents who conduct preliminary assessments.  I don't know if they invite all potential respondents or a limited number, say 10.  Also unknown is do they invite corporations who'd only be interested in both products, which doesn't seem smart, or say 10 for each, or a combo.
Either way this stage has passed.  I suspect management have already been over to conduct presentations among other things.  Recall from I think the half yearly a 300k 'admin' expense; my thoughts are this is associated with negotiations to date.
Navigant will have vetted respondents and narrowed the list down to say 10 serious companies with a range of expressed interest in either or both products including I hope interest in licensing Pericoach.  In the TGA ann., the wording of which I believe in hindsight was very deliberate, was the comment '... and further progress negotiations' or along those lines.  To my mind this hints at the process stalling pending the extremely significant outcome of the TGA's verdict for POP indication.
Though stalled all parties would have remained active in relevant associated aspects so it's not an issue.  So the serious stuff of Due Diligence by remaining participants starts including getting into the Data Room, which is just a secure sight, probably virtual, in which those shortlisted interested corporations check everything about our business, way too many things to list here.
There's nothing to fear from this as we know the exceptional Dr. Peter Corr went through everything then became a strategic partner.  However, I imagine the fact sales of Pericoach did not go well will be a strongly noted negative used against us in negotiations.  A countering positive is that throughout the entire process Navigant fosters a competitive bidding environment.
On completion of this stage final proposals from shortlisted multinationals are assessed. We could have hypothetically several offers of a buyout, interests in partnering, a request for licensing; for one or both products. Finalists are now selected for the serious negotiations.  Again hypothetically this might include 2 offers to buy ASB, one offer to license Pericoach, one offer to buy half the company for 20 mill and carry the load. Eventually definitive agreement/s are reached, deal/s closed, announced to market and the sp WILL rocket at warp speed.
One thing we can be totally sure of is that between Navigant and Corr, who's interests are aligned with ours, we will get the best possible deal.  
Also consider that Navigant spends a fortune throughout this, expecting probably 10 % from a big deal.  Analytica Medical might be tiny, but the product/s put us in the league that makes this viable for Navigant.  A $2m success fee doesn't suit them; $20 mill does.
Until that deal is announced we can excite ourselves with the reality of many multinationals looking at our innovative, effective, market leading products; the massive markets our products very effectively address, and the myriad of favorable trends.